Literature DB >> 25533800

Anticoagulation therapy: Reducing factor XI with antisense oligonucleotides superior to endoxaparin for postoperative venous thromboembolism.

João H Duarte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25533800     DOI： 10.1038/nrcardio.2014.214

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Making (anti)sense of factor XI in thrombosis.

Authors:  Robert Flaumenhaft
Journal:  N Engl J Med       Date:  2014-12-07       Impact factor: 91.245

2.  Factor XI antisense oligonucleotide for prevention of venous thrombosis.

Authors:  Harry R Büller; Claudette Bethune; Sanjay Bhanot; David Gailani; Brett P Monia; Gary E Raskob; Annelise Segers; Peter Verhamme; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2014-12-07       Impact factor: 91.245
  2 in total
  1 in total

1.  FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow.

Authors:  Shu Zhu; Richard J Travers; James H Morrissey; Scott L Diamond
Journal:  Blood       Date:  2015-07-01       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.